The DOI matches its Crossref record; 187 of the 187 references it cites were found in a registry or an index.
Diabetes and cancer
Open accessAbstract
Diabetes and cancer are two heterogeneous, multifactorial, severe, and chronic diseases. Because of their frequency, reciprocal influences - even minor influences - may have a major impact. Epidemiological studies clearly indicate that the risk of several types of cancer (including pancreas, liver, breast, colorectal, urinary tract, and female reproductive organs) is increased in diabetic patients. Mortality is also moderately increased. Several confounding factors, having general or site-specific relevance, make it difficult to accurately assess cancer risk in diabetic patients. These factors include diabetes duration, varying levels of metabolic control, different drugs used for therapy, and the possible presence of chronic complications. Hyperinsulinemia most likely favors cancer in diabetic patients as insulin is a growth factor with pre-eminent metabolic but also mitogenic effects, and its action in malignant cells is favored by mechanisms acting at both the receptor and post-receptor level. Obesity, hyperglycemia, and increased oxidative stress may also contribute to increased cancer risk in diabetes. While anti-diabetic drugs have a minor influence on cancer risk (except perhaps the biguanide metformin that apparently reduces the risk), drugs used to treat cancer may either cause diabetes or worsen a pre-existing diabetes. In addition to the well-known diabetogenic effect of glucocorticoids and anti-androgens, an increasing number of targeted anti-cancer molecules may interfere with glucose metabolism acting at different levels on the signaling substrates shared by IGF-I and insulin receptors. In conclusion, diabetes and cancer have a complex relationship that requires more clinical attention and better-designed studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Diabetes is associated with reduced risk of prostate cancer.”
From Diabetes and Cancer (2010) · cites this paper as [6]
In the citing paper
“Diabetes (primarily type 2) is associated with increased risk for some cancers (liver, pancreas, endometrium, colon and rectum, breast, bladder).”
From Diabetes and Cancer (2010) · cites this paper as [6]
In the citing paper
“Epidemiologic evidence suggests that people with diabetes are at significantly higher risk for many forms of cancer.”
From Diabetes and Cancer (2010) · cites this paper as [6]
In the citing paper
“For some other cancer sites there appears to be no association or the evidence is inconclusive.”
From Diabetes and Cancer (2010) · cites this paper as [6]
In the citing paper
“Other cancers (e.g., lung) do not appear to be associated with an increased risk in diabetes, and the evidence for others (e.g., kidney, non-Hodgkin lymphoma) is inconclusive.”
From Diabetes and Cancer (2010) · cites this paper as [6]
In the citing paper
“The relative risks imparted by diabetes are greatest (about twofold or higher) for cancers of the liver, pancreas, and endometrium, and lesser (about 1.2–1.5 fold) for cancers of the colon and rectum, breast, and bladder.”
From Diabetes and Cancer (2010) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
Hoskins, R. G. (1953) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-13-4-473 · Cited by 3,780
THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(1911) · JAMA · doi:10.1001/jama.1911.04260070032017 · Cited by 3,355
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
Metformin and reduced risk of cancer in diabetic patients
Evans, J. M. M., Donnelly, L. A., Emslie-Smith, A. M., Alessi, D. R., & Morris, A. D. (2005) · BMJ · doi:10.1136/bmj.38415.708634.f7 · Cited by 2,388
Giovannucci, E., Harlan, D. M., Archer, M. C., Bergenstal, R. M., Gapstur, S. M., Habel, L. A., Pollak, M., Regensteiner, J. G., & Yee, D. (2010) · Diabetes Care · doi:10.2337/dc10-0666 · Cited by 2,366
The American Journal of Gastroenterology
(2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.80003397.x · Cited by 2,202
Insulin and insulin-like growth factor signalling in neoplasia
Pollak, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2536 · Cited by 2,059
Archives of Biochemistry and Biophysics
Carter, H. E., Bhattacharyya, P., Weidman, K. R., & Fraenkel, G. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1981.tb06727.x · Cited by 1,895
Research works printed but not linked: 1
- Lindblad P Adami HO 2002 Kidney cancer. In Textbook of Cancer Epidemiology, pp 467–485 Eds HunterDAdamiHOTrichopoulosD. New York: Oxford University Press.
Cited by
Sorted by citations
Items 701–800 of 1,000
A Novel Approach for the Diagnosis of Diabetes and Liver Cancer using ANFIS and Improved KNN
Kalaiselvi, C., & Nasira, G. M. (2014) · Research Journal of Applied Sciences Engineering and Technology · doi:10.19026/rjaset.8.966 · Cited by 6
Loilome, W., Dokduang, H., Suksawat, M., & Padthaisong, S. (2021) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2021.1955102 · Cited by 7
The effects of glipizide on DNA damage and nuclear transport in differentiated 3T3-L1 adipocytes
Çevik, M., Caker, S., Deliorman, G., Çağatay, P., Gündüz, M. K., & Duman, B. S. (2022) · Molecular Biology Reports · doi:10.1007/s11033-021-06942-5 · Cited by 6
Acute coronary syndrome in patients with cancer
Shobayo, F. O., Bajwa, M., Koutroumpakis, E., Hassan, S. A., Palaskas, N. L., Iliescu, C., Abe, J., Mouhayar, E., Karimzad, K., Thompson, K., et al. (2022) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2022.2063840 · Cited by 7
Gu, L., Ma, G., Li, C., Lin, J., & Zhao, G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.958170 · Cited by 6
“Epidemiological results have suggested that there is a strong association between diabetes and cancers (especially liver and pancreatic cancers) (18).”
BackgroundInsulin therapy: Side effects and their management
Kashi, Z., Akha, O., Borzouei, S., & Bahar, A. (2013) · Clinical Excellence · Cited by 6
Fröhlich, E., & Wahl, R. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01491.x · Cited by 6
Metformin-associated lactic acidosis and temporary ileostomy: a case report
Margiani, C., Zorcolo, L., Mura, P., Saba, M., Restivo, A., & Scintu, F. (2014) · Journal of Medical Case Reports · doi:10.1186/1752-1947-8-449 · Cited by 6
Insulin Resistance and Inflammation in Black Women with and without Breast Cancer: Cause for Concern
Griffith, K. A., Chung, S.-Y., Zhu, S., & Ryan, A. S. (2016) · Ethnicity & Disease · doi:10.18865/ed.26.4.513 · Cited by 6
Gao, R., Man, T.-S., Liang, J., Wang, L., Zhu, H., Wu, W., Fan, L., Li, J., Yang, T., & Xu, W. (2019) · Cancer Research and Treatment · doi:10.4143/crt.2019.122 · Cited by 6
Kodama, Y., Ozaki, K., Sano, T., Matsuura, T., & Narama, I. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01589.x · Cited by 6
Pinto, A. V. L. (2014) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000132 · Cited by 7
Li, Z., Li, H., Wang, P., Xie, W. C., Shao, G., & Zhu, H. (2025) · Scientific Reports · doi:10.1038/s41598-025-12094-4 · Cited by 5
“…represent a significant cause of mortality among diabetic patients, along with cardiovascular disease, and diabetes has been shown to elevate the risk of specific cancers,including pancreatic, liver, breast, colorectal, urinary, and gynecological tumors 18–20 with elevated glucose levels 21 .”
Cardiometabolic perturbations arising from treatment with novel anticancer therapies
Bennetts, J. D., Sverdlov, A. L., & Ngo, D. T. M. (2025) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2025.10.008 · Cited by 5
Xia, D., Jin, L., Wang, B., Jin, Y., Qun, Z., Xu, J., & Chen, S. (2025) · Scientific Reports · doi:10.1038/s41598-024-84294-3 · Cited by 5
CXCL12 links bladder cancer and diabetes as a potential biomarker
Ma, M., Wang, S., Wang, K., Jiang, B., Li, J., & Hou, S. (2025) · Scientific Reports · doi:10.1038/s41598-025-01357-9 · Cited by 5
Antitumor Effects and Mechanisms of Metabolic Syndrome Medications on Hepatocellular Carcinoma
Oura, K., Morishita, A., Tani, J., & Masaki, T. (2022) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s392051 · Cited by 5
Kim, K., Kim, B., Kim, H., Park, H. S., Ahn, Y., Ko, S., Han, K., & Yun, J. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110866 · Cited by 5
Gao, X., Qian, J., Zhang, Y., Wang, H., Cui, J., & Yang, Y. (2023) · Proteome Science · doi:10.1186/s12953-023-00216-7 · Cited by 5
Deglycation activity of the Escherichia coli glycolytic enzyme phosphoglucose isomerase
Boteva, E., Doychev, K., Kirilov, K., Handzhiyski, Y., Tsekovska, R., Gatev, E., & Mironova, R. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.128541 · Cited by 5
Select Endocrine Disorders and Exosomes in Early PDAC Diagnosis
Włodarczyk, B., Durko, Ł., Walczak, K., Talar‐Wojnarowska, R., & Malecka-Wojciesko, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212159 · Cited by 5
Incidence of cancer among diabetic and non-diabetic adult Israeli Arabs.
Idilbi, N. M., Barchana, M., Milman, U., & Carel, R. S. (2013) · PubMed · Cited by 5
Role of breast cancer inhibitors on diabetes mellitus– an in silico approach
Rampogu, S. D. (2015) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-015-0138-1 · Cited by 5
Hyperglycemia among hospitalized cancer patients with coexisting diabetes mellitus
Karlin, N. J., Cheng, M., Castro, J. C., & Cook, C. B. (2015) · Diabetes Management · doi:10.2217/dmt.15.36 · Cited by 5
Diabetes mellitus als prognostischer Marker beim Oropharynx- und Larynxkarzinom
Zaoui, K., Doll, J., Stiebi, P., Federspil, P. A., Plinkert, P. K., & Hess, J. (2016) · HNO · doi:10.1007/s00106-016-0177-z · Cited by 5
Akintunde, J. K., Adebayo, A. J., Oluwadamilola, S. O., & Arinola, A. A. (2016) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000715 · Cited by 5
Dąbrowski, M., Szymańska‐Garbacz, E., Miszczyszyn, Z., Dereziński, T., & Czupryniak, L. (2017) · Oncotarget · doi:10.18632/oncotarget.17716 · Cited by 5
Thuesen, A. C. B., & Vaag, A. A. (2018) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13238 · Cited by 5
Coleman, N., Michalarea, V., Alken, S. P., Rihawi, K., Pérez-López, R., Tunariu, N., Petruckevitch, A., Molife, L. R., Banerji, U., Bono, J. S. D., et al. (2018) · Journal of Neuro-Oncology · doi:10.1007/s11060-018-2847-z · Cited by 5
Matsui, C., Takatani‐Nakase, T., Maeda, S., & Takahashi, K. (2018) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b18-00174 · Cited by 5
Brzački, V., Nagorni, A. V., Kallistratos, M. S., Manolis, A. J., & Lović, D. B. (2019) · Current Pharmacology Reports · doi:10.1007/s40495-019-00183-8 · Cited by 5
Synergistic Behavior of Phytophenolics with Antidiabetic Drugs
Hoda, M., Hemaiswarya, S., & Doble, M. (2019) · Springer eBooks · doi:10.1007/978-981-13-8997-9_5 · Cited by 5
Mortality disparities: A comparison with the Haudenosaunee in New York State.
Haring, R. C., Jim, M. A., Erwin, D. O., Kaur, J. S., Henry, W. A. E., Haring, M., & Seneca, D. S. (2018) · PubMed · doi:10.9777/chd.2018.10009 · Cited by 7
Abooshahab, R., Hooshmand, K., Al‐Salami, H., & Dass, C. R. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15082140 · Cited by 5
Insulin-resistant conditions: A favorable milieu for aggressive drug-resistant malignancies.
Landriscina, M., & Esposito, F. (2011) · PubMed Central · doi:10.3978/j.issn.2078-6891.2011.004 · Cited by 5
Epidemiology of Renal Cell Carcinoma
Sánchez, A., Allard, C. B., & Wilson, K. M. (2016) · Springer eBooks · doi:10.1007/978-3-319-35153-7_17 · Cited by 5
Application possibilities of biguanides for fibrocystic breast disease in women of reproductive age
Валентиновна, М. Е., & Kogan, I. Y. (2019) · Journal of obstetrics and women s diseases · doi:10.17816/jowd68335-40 · Cited by 5
Elbasan, O., & Yavuz, D. G. (2021) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000361 · Cited by 5
The Effect of Insulin Resistance on Breast Cancer Risk in Latinas of Mexican Origin
Cordero-Franco, H. F., Salinas-Martı́nez, A. M., Abundis, A. R., Espinosa-Flores, E. M., Vázquez-Lara, J., & Guerrero‐Romero, F. (2014) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2014.0071 · Cited by 5
Sessile serrated adenomas versus conventional adenomas. Different polyps in different populations?
Michalopoulos, G., Vrakas, S., Ntouli, V., Lamprinakos, S., Makris, K., & Tzathas, C. (2015) · Indian Journal of Gastroenterology · doi:10.1007/s12664-015-0562-7 · Cited by 5
Moe, B., & Nilsen, T. I. L. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.12.001 · Cited by 5
The association between regular use of aspirin and the prevalence of prostate cancer
Huang, W., Erickson, S. R., Hansen, R. A., & Wu, C. (2016) · Medicine · doi:10.1097/md.0000000000003909 · Cited by 5
Banal, K. A. C., Paz-Pacheco, E. T., & de Villa, V. (2017) · Journal of the ASEAN Federation of Endocrine Societies · doi:10.15605/jafes.032.01.06 · Cited by 5
Abdullah, S., & Chatterjee, P. K. (2025) · Phytomedicine Plus · doi:10.1016/j.phyplu.2025.100772 · Cited by 4
Glucose-dependent insulin-like growth factor 1 secretion promotes breast cancer cell tumorigenesis
Gentilini, V., Annibalini, G., Baldelli, G., Conti, A. M. F., Emili, R., Brandi, G., Barbieri, E., & Santi, M. D. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.124020 · Cited by 4
Ferreira, G., Chavarría, L., DeMarco, A., Bernech, F., Cardozo, R., Santander, A., Domínguez, L., Mujica, N., Sobrevía, L., & Nicolson, G. L. (2025) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2025.101426 · Cited by 4
Infection in Diabetes: Epidemiology, Immune Dysfunctions, and Therapeutics
Roy, R., Singh, R. K., & Shafikhani, S. H. (2024) · Contemporary diabetes · doi:10.1007/978-3-031-55715-6_17 · Cited by 4
Niţipir, C., Barbu, M. A., Orlov, C., Stanciu, A. E., Popa, A. M., Hainăroșie, R., Pițuru, S., Arsene, A. L., & Stoian, A. P. (2019) · ROMANIAN BIOTECHNOLOGICAL LETTERS · doi:10.25083/rbl/24.1/140.146 · Cited by 4
Seth, S., & Gallagher, E. J. (2023) · Endocrine Practice · doi:10.1016/j.eprac.2023.06.006 · Cited by 4
Manna, S., Banerjee, S., De, A., Banerjee, S., Das, S., Rakshit, P., K, A. K. S., Sen, K. K., & De, S. (2024) · Pharmaceutical Nanotechnology · doi:10.2174/0122117385314533240824090949 · Cited by 4
Wang, Y., Fang, Y., Habenicht, A. J. R., Golledge, J., Giovannucci, E. L., & Ceriello, A. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.70008 · Cited by 4
Basal insulin analogues--a review of recent data on efficacy and safety.
John, M. (2011) · PubMed · Cited by 4
Advances in the prevention, diagnosis and therapy of vascular diseases
Szabó, K., Ádány, R., Balla, J., Balogh, Z., Boda, Z., Edes, I. F., Fekete, I., Káplár, M., Mátyus, J., Oláh, L., et al. (2012) · Orvosi Hetilap · doi:10.1556/oh.2012.29340 · Cited by 4
Diabetes, obesity and cancer: risk and anti-risk factors
Берштейн, Л. М. (2012) · Diabetes Mellitus · doi:10.14341/2072-0351-5543 · Cited by 4
The Anticancer Effect of Metformin, the Most Commonly Used Anti-Diabetes Drug
Meng, S. (2014) · Cited by 4
Spadigam, A. E., Dhupar, A., Syed, S., & Saluja, T. S. (2016) · Indian Journal of Medical and Paediatric Oncology · doi:10.4103/0971-5851.177002 · Cited by 4
Hyperglycemia and Cancer: An Algorithm to Guide Oncology Nurses
Sampayo, V., & Tofthagen, C. (2017) · Clinical journal of oncology nursing · doi:10.1188/17.cjon.345-352 · Cited by 4
Fujii, T., Ohisa, M., Sako, T., Harakawa, T., Sakamune, K., Nagashima, S., Sugiyama, A., Matsuura, Y., & Tanaka, J. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14020 · Cited by 4
The impact of lipomatous tumors on type 2 diabetes: are adipose-derived tumors metabolically active?
Fallahian, F., Ardestani, A., Pranckevicius, E., Raut, C. P., Tavakkoli, A., & Sheu, E. G. (2017) · Journal of Surgical Research · doi:10.1016/j.jss.2017.09.040 · Cited by 4
Diabetes and Pancreatic Cancer: A Bidirectional Relationship Perspective
Gupta, M. K., Sarojamma, V., & Vadde, R. (2019) · Springer eBooks · doi:10.1007/978-981-32-9393-9_3 · Cited by 4
METNET: a phase II trial of metformin in patients with well-differentiated neuroendocrine tumours
Glasberg, J., Talans, A., Rivelli, T. G., Recchimuzzi, D. Z., Neto, J. E. B., López, R. V. M., Hoff, P. M., & Riechelmann, R. P. (2022) · ecancermedicalscience · doi:10.3332/ecancer.2022.1369 · Cited by 4
Minimizing Mitogenic Potency of Insulin Analogues Through Modification of a Disulfide Bond
Ong, S. C., Belgi, A., Merriman, A., Delaine, C. A., van Lierop, B. J., Andrikopoulos, S., Robinson, A. J., & Forbes, B. E. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.907864 · Cited by 5
Regression of ovarian cancer xenografts by depleting or inhibiting RLIP
Ramisetty, S. K., Garg, P. K., Mohanty, A. R., Mirzapoiazova, T., Yue, E., Wang, W., Horne, D. A., Awasthi, S., Kulkarni, P., Salgia, R., et al. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115847 · Cited by 4
Li, M., Roder, D. M., & McDermott, R. A. (2018) · International Journal of Cancer · doi:10.1002/ijc.31403 · Cited by 4
Systematic Survey of the Role of IGF in the Link Between Diabetes and Cancer
Devanathan, N., & Kimble-Hill, A. C. (2018) · IU Journal of Undergraduate Research · doi:10.14434/iujur.v4i1.24499 · Cited by 4
Uncoupling Obesity from Cancer: Bromodomain Co-regulators That Control Inflammatory Networks
Denis, G. V., & Bowen, D. J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6819-6_3 · Cited by 4
“Signal transduction through the insulin receptor and IGF-1 receptor [149] is thought to increase cancer risk in obesity [30, 94].”
BackgroundAtsumi, T. (2015) · Diabetology International · doi:10.1007/s13340-015-0227-x · Cited by 4
Bailey, C. J. (2013) · Springer eBooks · doi:10.1007/978-3-7091-1331-8_8 · Cited by 4
Potential Mechanisms Linking Insulin to Cancer
Babichev, Y., Khalid, S., & Fantus, I. G. (2011) · Energy balance and cancer · doi:10.1007/978-1-4419-9911-5_7 · Cited by 4
“Many studies have documented using both cross-sectional and prospective data that obesity as well as type 2 diabetes mellitus (T2DM) are associated with an increased incidence and mortality of BC [84, 85, 93, 137 , 145].”
BackgroundYang, X., & Chan, J. C. N. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.9677 · Cited by 4
Bardaweel, S. K., Sneineh, B. A., Hajjo, R., & Khalaf, R. A. (2025) · PLoS ONE · doi:10.1371/journal.pone.0334223 · Cited by 3
“Over the last two decades, evidence has begun to accumulate supporting the role of glucose metabolism in cancer development and progression, and a solid relationship between diabetes and the occurrence of several types of cancers has been established [11,12].”
Overcoming Curcumin's Limitations: Synthetic Derivatives in Diabetes and Cancer Management
Adeleye, A. O., Dena, S. M., Oguntibeju, O. O., Titinchi, S. J. J., & Opuwari, C. S. (2025) · Applied Research · doi:10.1002/appl.70049 · Cited by 3
Metabolic dysregulation: Its role in diabetes mellitus and cancers
Dai, S., Li, J., Xia, J., Liu, Y., & Li, Y. (2026) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2026.101461 · Cited by 3
Targeting Breast Cancer in Diabetic Mice Using a Combination of Thymoquinone and Metformin
Aboulqassim, N. S. S., & Talib, W. H. (2022) · The Natural Products Journal · doi:10.2174/2210315512666220615114025 · Cited by 3
Sergeyev, A., Gu, L., Hoedt, A. M. D., Amling, C. L., Aronson, W. J., Cooperberg, M. R., Kane, C. J., Klaassen, Z. W. A., Terris, M. K., Guerrios‐Rivera, L., et al. (2023) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-22-1324 · Cited by 3
Stan, M. C., Mireștean, C. C., Stoica, D., Popescu, F. C., & Bădulescu, F. (2023) · Romanian Journal of Morphology and Embryology · doi:10.47162/rjme.64.3.12 · Cited by 3
The Role of Inositols in Endocrine and Neuroendocrine Tumors
Mormando, M., Puliani, G., Bianchini, M., Lauretta, R., & Appetecchia, M. (2024) · Biomolecules · doi:10.3390/biom14081004 · Cited by 3
Li, M., Huang, J., Lu, W., Guo, Y., Xia, G., & Hu, Q. (2024) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2024.09.007 · Cited by 3
Barati, H., Madani, A. M., Shadzinavaz, S., & Fardmanesh, M. (2024) · Applied Spectroscopy · doi:10.1177/00037028241300535 · Cited by 3
Prevalence and predictors of cancer among diabetic individuals in the United States
Ekwebene, O. C., Mensah, E. A., Ekwebene, C. F., Olagunju, O. J., Edeh, G. C., Eleje, G. U., & Suleiman, M. M. A. (2024) · Discover Epidemics · doi:10.1007/s44203-024-00002-7 · Cited by 3
Streptozotocin-induced hyperglycemia unmasks cardiotoxicity induced by doxorubicin
Nicol, M., Deniau, B., Rahli, R., Genest, M., Polidano, E., Assad, N., Samuel, J., Mebazaa, A., Solal, A. C., & Azibani, F. (2025) · Scientific Reports · doi:10.1038/s41598-025-91824-0 · Cited by 3
Li, C., Chen, T., Li, Y., Zhou, C., Du, J., Li, X., Tang, C., Ma, C., Deng, N., & Cui, H. (2025) · Discover Oncology · doi:10.1007/s12672-025-02425-2 · Cited by 3
Translational Endocrinology & Metabolism: Metabolic Surgery Update
DEL PRATO, S., & Lebovitz, H. E. (2012) · Translational endocrinology & metabolism · doi:10.1210/team.9781936704071 · Cited by 3
Bánhegyi, R. J., Gazdag, A., Rácz, B., Beke, S., & Fülöp, N. (2022) · Orvosi Hetilap · doi:10.1556/650.2022.32564 · Cited by 3
Smith, L., von Wagner, C., Kaushal, A., Rafiq, M., Lyratzopoulos, G., & Renzi, C. (2023) · Cancers · doi:10.3390/cancers15061668 · Cited by 3
“Diabetes is associated with an increased risk of developing CRC [5] through complex biological mechanisms related to insulin-like growth factors, insulin resistance, compensatory increased insulin levels, and prolonged hyperglycaemia [6,7].”
BackgroundMkuu, R. S., Hall, J., Galochkina, Z., Cho, H. D., Staras, S. A. S., Lee, J., Guo, Y. M., Chakrabarti, C., Barrow, S. B., Ortega, S., et al. (2023) · Healthcare · doi:10.3390/healthcare11131863 · Cited by 3
“Several cancers among women, including colorectal, breast, and endometrial, have been associated with T2D [2,3].”
BackgroundTeng, A. M., Stanley, J., Lawrenson, R. A., Lao, C., Krebs, J. D., Koea, J., Sika‐Paotonu, D., & Gurney, J. (2024) · Cancer Epidemiology · doi:10.1016/j.canep.2024.102723 · Cited by 3
Chen, Y., Lu, J.-Y., Huang, C., & Shao, Y. J. (2025) · International Journal of Cardiology Cardiovascular Risk and Prevention · doi:10.1016/j.ijcrp.2025.200468 · Cited by 3
Antidiabetikus kezelés, mint újabb lehetőség a daganatok komplex terápiájában
Bánhegyi, R. J., Rus-Gal, P. O., Nagy, Á. K., Martyin, T., Wagner, R. J., Varga, R., & Pikó, B. (2010) · Magyar Onkológia · doi:10.1556/monkol.54.2010.4.5 · Cited by 3
Comparison between Machine Learning Algorithms in the Predicting the Onset of Diabetes
Abed, M., & İbrikçі, T. (2019) · International Artificial Intelligence and Data Processing Symposium (IDAP) · doi:10.1109/idap.2019.8875965 · Cited by 3
Paraneoplastic Syndromes in Pancreatic Cancer
Werner, J., & Herzig, S. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7193-0_27 · Cited by 3
Correlation between diabetes prevalence and subsequent cancer mortality in North Carolina counties
Spangler, J. G., & Kirk, J. K. (2014) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2014.41001 · Cited by 3
McLean, R. C., & Logue, J. (2014) · Current Nutrition Reports · doi:10.1007/s13668-014-0105-3 · Cited by 3
Jalil, N. A. C., Zin, A. A. M., & Othman, N. H. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.16.7267 · Cited by 3
Cander, S., Gül, Ö. Ö., Dizdar, O. S., Koca, N., Aydın, T., Sarandöl, E., & Ersoy, C. (2017) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2017.0005 · Cited by 3
Towards Evidence Based M-Health Application Design in Cancer Patient Healthy Lifestyle Interventions
Antoniou, P. E., Rivera-Romero, O., Karagianni, M. A., & Bamidis, P. D. (2017) · Proceedings - IEEE Symposium on Computer-Based Medical Systems · doi:10.1109/cbms.2017.117 · Cited by 3
Toi, M., Ohashi, Y., Seow, A., Moriya, T., Tse, G. M.-K., Sasano, H., Park, B., Chow, L. W. C., Laudico, A. V., Yip, C. H., et al. (2010) · Cited by 3
Wang, J.-H., Pan, C.-H., Chang, I., & Hsiung, C. A. (2019) · Lifetime Data Analysis · doi:10.1007/s10985-019-09475-z · Cited by 3
“DM has been associated consistently with an increased risk of cancers of the liver, pancreas, and endometrium (Vigneri et al. 2009).”
BackgroundCancer risk in dialyzed patients with and without diabetes
Pladys, A., Défossez, G., Lemordant, P., Lassalle, M., Ingrand, P., Jacquelinet, C., Riou, C., Bouzillé, G., van Hille, P., Vigneau, C. M., et al. (2020) · Cancer Epidemiology · doi:10.1016/j.canep.2020.101689 · Cited by 3
“A Sweden study showed that type 2 diabetes is associated with higher standardized incidence rates of cancer in pancreas and liver [14], two organs affected by the metabolic alterations linked to diabetes (15).”
BackgroundAyoub, N. M., Yaghan, R. J., Al-Mohtaseb, A. H., Aldaoud, N., Matalka, I. I., & Elhassan, M. E. (2020) · Applied Sciences · doi:10.3390/app10051614 · Cited by 4
Metadata
- Authors
- Vigneri, P., Frasca, F., Sciacca, L., Pandini, G., & Vigneri, R.
- Affiliations
- Section of General Pathology 1
- University of Catania (IT)
- Corresponding author
- Vigneri, Paolo
- Venue
- Endocrine Related Cancer
- Publisher
- Bioscientifica
- Published
- 2009-12-01
- Volume
- 16
- Issue
- 4
- Pages
- 1103-1123
- ISSN
- 1351-0088 (ISSN-L)
- 1479-6821
- OpenAlex
- W2163691729
- Cited by
- 1,009
- References
- 183
- Citations by year
- 2026: 20 · 2025: 43 · 2024: 54 · 2023: 49 · 2022: 49 · 2021: 46 · 2020: 50 · 2019: 57 · 2018: 60 · 2017: 75 · 2016: 59 · 2015: 68 · 2014: 85 · 2013: 97 · 2012: 80
- FWCI
- 5.00
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Endocrine Related Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Associazione Italiana per la Ricerca sul Cancro
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Keywords
- diabetes mellitus, cancer risk, hyperinsulinemia, insulin-like growth factor I, insulin receptor, metformin, antidiabetic drugs, glucocorticoids, androgen receptor antagonists, obesity, hyperglycemia, oxidative stress, pancreatic cancer, liver cancer, breast cancer, colorectal cancer, cancer mortality, confounding factors
- MeSH terms
- Humans, Neoplasms, Risk Factors, Survival Rate, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
